Affordable Access

Therapy for recurrent malignant glioma in adults.

Authors
Type
Published Article
Journal
Expert Review of Anticancer Therapy
Publisher
Informa UK (Taylor & Francis)
Volume
4
Issue
5
Pages
759–782
Source
Kesari Lab
License
Unknown

Abstract

Malignant gliomas are the most common form of primary brain tumors in adults. Although the prognosis remains poor, there has been recent progress in the treatment of these tumors. Standard therapy for patients with this disease will be reviewed, together with more novel approaches such as targeted molecular therapies, angiogenesis inhibitors, immunotherapies, gene therapies and intratumoral therapies.

Report this publication

Statistics

Seen <100 times